** Shares of Regal Asian Investments RG8.AX fall as much as 3.8% to A$1.915, their lowest level since Dec 8, 2023
** Stock posts biggest intraday decline since Feb 20
** Investment manager devalues stake in biotech Opthea OPT.AX to A$0.20/shr vs OPT's last close of A$0.60 before trading was suspended
** OPT on Monday warned of insolvency after its late-stage trial for its wet age-related macular degeneration injection failed
** RG8 stock last down 2%, bringing YTD losses to 8.9%.
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.